Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).

[1]  J. Risteli,et al.  Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. , 1988, Clinical chemistry.

[2]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[3]  M. Hori,et al.  High prevalence of atrial fibrosis in patients with dilated cardiomyopathy. , 1995, Journal of the American College of Cardiology.

[4]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[5]  L. Kuller,et al.  Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.

[6]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[7]  M. Allessie,et al.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[8]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[9]  I. Kodama,et al.  Anisotropic Conduction Properties in Canine Atria Analyzed by High-Resolution Optical Mapping: Preferential Direction of Conduction Block Changes From Longitudinal to Transverse With Increasing Age , 2002, Circulation.

[10]  M. Rosen,et al.  Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. , 2002, Cardiovascular research.

[11]  S. Nattel,et al.  Atrial Ischemia Promotes Atrial Fibrillation in Dogs , 2003, Circulation.

[12]  Sander Verheule,et al.  Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.

[13]  P. Marino,et al.  Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. , 2004, Journal of cardiac failure.

[14]  S. Nattel,et al.  Dissociation Between Ionic Remodeling and Ability to Sustain Atrial Fibrillation During Recovery From Experimental Congestive Heart Failure , 2004, Circulation.

[15]  Bruce M Psaty,et al.  Fish intake and risk of incident atrial fibrillation. , 2004, Circulation.

[16]  M. Capecchi,et al.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. , 2004, The American journal of pathology.

[17]  M. Rosen,et al.  Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. , 2005, Cardiovascular research.

[18]  V. Shusterman,et al.  Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. , 2005, American journal of physiology. Heart and circulatory physiology.

[19]  G. Edwards,et al.  Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. , 2006, European heart journal.

[20]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[21]  T. Murohara,et al.  Circulating adiponectin levels in patients with atrial fibrillation. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[22]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[23]  H. Pak,et al.  Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  Y. On,et al.  Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. , 2009, The Journal of thoracic and cardiovascular surgery.

[25]  J. Gottdiener,et al.  Association Between Elevated Fibrosis Markers and Heart Failure in the Elderly: The Cardiovascular Health Study , 2009, Circulation. Heart failure.

[26]  Richard A. Kronmal,et al.  N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study , 2009, Circulation.

[27]  Ulrich Schotten,et al.  Fibrillatory Conduction in the Atrial Free Walls of Goats in Persistent and Permanent Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.

[28]  E. Benjamin,et al.  Relations of Biomarkers of Extracellular Matrix Remodeling to Incident Cardiovascular Events and Mortality , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[29]  E. Kholmovski,et al.  Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. , 2010, Heart rhythm.

[30]  M. Borggrefe,et al.  Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure , 2011, Clinical Research in Cardiology.

[31]  M. Kawamura,et al.  Candesartan Decreases Type III Procollagen-N-Peptide Levels and Inflammatory Marker Levels and Maintains Sinus Rhythm in Patients With Atrial Fibrillation , 2010, Journal of cardiovascular pharmacology.

[32]  K. Jeong,et al.  Frequency of vacuolating cytotoxin A (VacA)-positive Helicobacter pylori seropositivity and TGF-β1 decrease in atrial fibrillation. , 2010, International journal of cardiology.

[33]  R. Kalluri,et al.  The origin of fibroblasts and mechanism of cardiac fibrosis , 2010, Journal of cellular physiology.

[34]  H. Pak,et al.  High plasma concentrations of transforming growth factor-β and tissue inhibitor of metalloproteinase-1: potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[35]  S. Baldus,et al.  Inflammatory pathways underlying atrial fibrillation. , 2011, Trends in molecular medicine.

[36]  P. Zimetbaum,et al.  Atrial Fibrillation and Atrial Fibrosis , 2010, Journal of cardiovascular pharmacology.

[37]  R. McKelvie,et al.  Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction: Results of the I-PRESERVE Collagen Substudy , 2011, Circulation. Heart failure.

[38]  P. Platonov,et al.  Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. , 2011, Journal of the American College of Cardiology.

[39]  E. Kholmovski,et al.  Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[40]  Chengwen Sun,et al.  20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways. , 2011, Journal of cardiovascular pharmacology.

[41]  J. D. de Bakker,et al.  Biomarkers of Myocardial Fibrosis , 2011, Journal of cardiovascular pharmacology.

[42]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[43]  Stefan L. Zimmerman,et al.  Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. , 2012, Heart rhythm.

[44]  A. Reiner,et al.  Transforming growth factor beta-1 and incidence of heart failure in older adults: the Cardiovascular Health Study. , 2012, Cytokine.

[45]  P. Ellinor,et al.  A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation. , 2012, Journal of atrial fibrillation.

[46]  O. Bruyère,et al.  Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease , 2013, BMC Nephrology.